Brand owners in the pharmaceutical sector are facing a challenge to find faster ways to launch brand protection measures. This challenge grows more complicated and time-consuming when pharma companies are managing brands across multiple jurisdictions. World Trademark Review recently published an interview with INTA president-elect David Lossignol, Global Head of Trademarks at Sandoz International GmbH, where he manages the company's global trademark portfolio. Corsearch is a partner of Sandoz.
